SynAct Pharma AB (STO:SYNACT)

SynAct Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	68.89	61.21	62.4	108.25	24	14.55
Cash & Short-Term Investments	68.89	61.21	62.4	108.25	24	14.55
Cash Growth	9.70%	-1.90%	-42.36%	351.08%	64.95%	315.06%
Other Receivables	18.94	14.43	12.41	14.7	10.67	6.46
Receivables	18.94	14.43	12.41	14.7	10.67	6.46
Prepaid Expenses	2.63	18.37	0.26	17.29	0.25	0.32
Other Current Assets	-	-0	-0	-0	0	-
Total Current Assets	90.46	94	75.06	140.23	34.92	21.33
Property, Plant & Equipment	1.57	1.94	0.66	2.1	3.18	-
Long-Term Investments	-	0.05	0.14	0.27	0.27	0.26
Long-Term Deferred Charges	151.43	154.59	152.16	-	-	-
Other Long-Term Assets	0.14	19.94	0	-	-	-
Total Assets	243.6	270.52	228.02	142.6	38.37	21.59
Accounts Payable	5.42	17.35	9.67	4.72	4.25	2.78
Accrued Expenses	13.07	10.09	9.82	4.91	7.89	2.76
Current Portion of Leases	0.61	0.6	0.58	1	0.98	-
Other Current Liabilities	0.38	0.42	4.88	4.38	2.27	0.19
Total Current Liabilities	19.46	28.46	24.94	15.01	15.39	5.73
Long-Term Leases	0.94	1.29	0.06	1.06	2.11	-
Long-Term Deferred Tax Liabilities	17.93	18.3	18.02	-	-	-
Other Long-Term Liabilities	8.85	8.3	8.82	-	-	-
Total Liabilities	47.18	56.35	51.83	16.08	17.5	5.73
Common Stock	6.23	5.81	4.45	3.71	3.25	3.05
Additional Paid-In Capital	799.98	762.8	646.57	394.84	193.6	119.4
Retained Earnings	-625.21	-573	-490.6	-274.79	-175.59	-106.28
Comprehensive Income & Other	15.41	18.56	15.77	2.77	-0.4	-0.3
Shareholders' Equity	196.41	214.17	176.19	126.52	20.87	15.87
Total Liabilities & Equity	243.6	270.52	228.02	142.6	38.37	21.59
Total Debt	1.54	1.88	0.64	2.06	3.09	-
Net Cash (Debt)	67.35	59.33	61.76	106.18	20.91	14.55
Net Cash Growth	9.75%	-3.94%	-41.84%	407.85%	43.72%	315.06%
Net Cash Per Share	1.48	1.50	1.90	3.85	0.81	0.68
Filing Date Shares Outstanding	49.87	46.49	35.57	31.82	26.01	24.41
Total Common Shares Outstanding	49.87	46.49	35.57	29.65	26.01	24.41
Working Capital	71	65.54	50.12	125.22	19.53	15.6
Book Value Per Share	3.94	4.61	4.95	4.27	0.80	0.65
Tangible Book Value	196.41	214.17	176.19	126.52	20.87	15.87
Tangible Book Value Per Share	3.94	4.61	4.95	4.27	0.80	0.65

Source: S&P Global Market Intelligence. Standard template. Financial Sources.